Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|January 22, 2010
Reshaping the healthcare delivery networkRonald Schmidt, Gene Altus
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 21, 2005
LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of ratsRonald Schmidt, Ovidiu Coste, Gerd Geisslinger
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|June 19, 2007
Convenient medical clinics reshaping the healthcare landscapeRonald Schmidt, Ray Kolar, Carrie Fairfield
Prostaglandins & Other Lipid Mediators|November 7, 2006
LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samplesHelmut Schmidt, Ronald Schmidt, Gerd Geisslinger
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 20, 2006
High sensitive determination of sufentanil in human plasma of parturients and neonates following patient-controlled epidural analgesia (PCEA)Ronald Schmidt, Dorothee H Bremerich, Gerd Geisslinger
Diabetes|April 28, 2005
Wound inflammation in diabetic ob/ob mice: functional coupling of prostaglandin biosynthesis to cyclooxygenase-1 activity in diabetes-impaired wound healingHeiko Kämpfer, Ronald Schmidt, Gerd Geisslinger, et al.
Biochemical Pharmacology|March 26, 2004
Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cellsThorsten Jürgen Maier, Karin Schilling, Ronald Schmidt, et al.
Pharmacogenetics and Genomics|August 15, 2006
The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriersBruno G Oertel, Ronald Schmidt, Andreas Schneider, et al.
Archives of Physiology and Biochemistry|August 22, 2014
Metabolic effect and receptor signalling profile of a non-metabolisable insulin glargine analogueUlrich Werner, Marcus Korn, Ronald Schmidt, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 11, 2005
Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cellsThorsten Jürgen Maier, Astrid Janssen, Ronald Schmidt, et al.
Pageof 3